This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Sk on Co., Ltd., Korea Advanced Institute of Science and Technology. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2017-2026
Title: The Innovative Contributions of Won Kyeong Kim
Introduction
Won Kyeong Kim is a prominent inventor based in Daejeon, South Korea. He has made significant strides in the field of genetic research, particularly in gene silencing techniques. His work has the potential to impact various applications in biotechnology and medicine.
Latest Patents
Won Kyeong Kim holds a patent for an "Effective method for specific gene silencing using artificial small RNA." This invention involves a nucleic acid molecule that comprises a stem-loop structure, along with a nucleic acid complex that includes this molecule. The composition is designed for delivering a target recognition sequence, which is crucial for effective gene silencing. The artificial small ribonucleic acid maintains the single-strandedness of the target recognition sequence, allowing it to interact with the nucleic acid of interest in prokaryotes. This innovation provides a robust method for silencing specific genes, showcasing Kim's expertise in molecular biology.
Career Highlights
Kim is affiliated with the Korea Advanced Institute of Science and Technology, where he continues to advance his research. His contributions to the field of gene silencing have garnered attention and recognition within the scientific community.
Collaborations
Some of his notable coworkers include Younghoon Lee and Geunu Bak, who have collaborated with him on various research projects. Their combined efforts have furthered the understanding and application of gene silencing technologies.
Conclusion
Won Kyeong Kim's innovative work in gene silencing represents a significant advancement in biotechnology. His patent and ongoing research contribute to the evolving landscape of genetic engineering and its applications in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile